|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Accretion of debt discount | |||||
| Gain on settlement of accounts payable | |||||
| Depreciation expense | |||||
| Impairment of acquired in-process research and development intangible assets | |||||
| Changes in operating assets and liabilities: | |||||
| Research and development tax credit receivable | |||||
| Other tax receivable | |||||
| Prepaid expenses and other current assets | |||||
| Prepaid expenses – related party | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accounts payable and accrued liabilities – related parties | |||||
| Deferred liabilities | |||||
| Accrued liability – long-term | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| CASH FROM INVESTING ACTIVITIES | |||||
| Purchase of fixed assets | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Cash proceeds for amendment of warrants | |||||
| Exercise of warrants for cash | |||||
| Repayment of debt | |||||
| Net proceeds from the exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Impact on cash from foreign currency translation | |||||
| NET INCREASE (DECREASE) IN CASH | |||||
| CASH AT BEGINNING OF YEAR | |||||
| CASH AT END OF YEAR | |||||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: | |||||
| Cash paid for interest expense | |||||
| SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Right of use assets obtained in exchange for lease obligations | |||||
Loading...